https://www.selleckchem.com/pr....oducts/acss2-inhibit
5% vs. 3.5%, p = 0.73; postoperative pneumonia 2.6% vs. 4.3%, p = 0.51) did not differ between the groups. Also, device success was comparable (96.9% vs. 93.9%, p = 0.24). In patients undergoing LAAC with the Watchman device, conscious sedation and general anesthesia showed comparable device success rates and safety outcomes. The type of anesthesia for LAAC may therefore be tailored to patient comorbidities, operator experience, and hospital logistics. In patients undergoing LAAC with the Watchman device, conscious sedation and